The heterotrimeric G protein subunits Gαq and Gβ1 have lysophospholipase D activity by Aoyama, Chieko et al.
Biochem. J. (2011) 440, 241–250 (Printed in Great Britain) doi:10.1042/BJ20110545 241
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In a previous study we puriﬁed a novel lysoPLD (lysophospho-
lipase D) which converts LPC (lysophosphatidylcholine) into a
bioactive phospholipid, LPA (lysophosphatidic acid), from the rat
brain.Inthepresentstudy,weidentiﬁedthepuriﬁed42and35 kDa
proteins as the heterotrimeric G protein subunits Gαq and Gβ1
respectively. When FLAG-tagged Gαq or Gβ1 was expressed in
cellsandpuriﬁed,signiﬁcantlysoPLDactivitywasobservedinthe
microsomal fractions. Levels of the hydrolysed product choline
increased over time, and the Mg
2+ dependency and substrate
speciﬁcity of Gαq were similar to those of lysoPLD puriﬁed
from the rat brain. Mutation of Gαq at amino acids Lys
52,T h r
186
or Asp
205, residues that are predicted to interact with nucleotide
phosphates or catalytic Mg
2+, dramatically reduced lysoPLD
activity.GTPdoesnotcompetewithLPCforthelysoPLDactivity,
indicating that these substrate-binding sites are not identical.
Whereas the enzyme activity of highly puriﬁed FLAG-tagged
Gαq overexpressed in COS-7 cells was ∼4 nmol/min per mg, the
activity from Neuro2A cells was 137.4 nmol/min per mg. The
calculated Km and Vmax values for lysoPAF (1-O-hexadecyl-sn-
glycero-3-phosphocholine) obtained from Neuro2A cells were
21 μM and 0.16 μmol/min per mg respectively, similar to the
enzyme puriﬁed from the rat brain. These results reveal a new
function for Gαq and Gβ1 as an enzyme with lysoPLD activity.
Tag-puriﬁed Gα11 also exhibited a high lysoPLD activity, but
Gαi and Gαs did not. The lysoPLD activity of the Gα subunit
is strictly dependent on its subfamily and might be important
for cellular responses. However, treatment of Hepa-1 cells with
Gαq and Gα11 siRNAs (small interfering RNAs) did not change
lysoPLD activity in the microsomal fraction. Clariﬁcation of the
physiological relevance of lysoPLD activity of these proteins
will need further studies.
Key words: autotaxin, Gαq,G β1, lysophosphatidic acid (LPA),
lysophosphatidylcholine(LPC),lysophospholipaseD(lysoPLD).
INTRODUCTION
LPA (lysophosphatidic acid) is a potentially bioactive phospho-
lipid that mediates a number of physiological processes,
including cell adhesion, proliferation, differentiation, survival
and migration. GPCRs (G-protein-coupled receptors) in the EDG
(endothelial differentiation gene) and P2Y families are speciﬁc
receptors for LPA in the plasma membrane, and intracellular
signalling via these GPCRs has been well characterized [1].
However, less is known about the physiological regulation of
LPA production or how LPA-speciﬁc receptors in the plasma
membranearestimulatedinvivo.Atleasttwoplausibleenzymatic
pathways for the production of LPA have been described. One of
these is the deacylation of PA (phosphatidic acid) by activated
PLA (phospholipase A) [2]. In support of this idea, a PA-selective
PLA1 (phospholipase A1) called mPA-PLA1α/LIPH (membrane-
associated phosphatidic acid-selective phospholipase A1α/lipase
member H) has been identiﬁed that hydrolyses acyl residues at
the sn−1 position of PA and enhances release of LPA from the
plasma membrane [3,4]. The other pathway for LPA production
is direct production of equimolar amounts of LPA and choline
from LPC (lysophosphatidylcholine), as catalysed by lysoPLD
(lysophospholipase D) [5,6].
The physiological importance of LPA production in serum by
lysoPLD was suggested by Tokumura et al. [7] approximately
25 years ago. In circulating blood, LPA modulates blood
pressure [8,9], maintenance of pregnancy [10] and maturation
of embryonic vessel systems [11]. Previously, a secreted
protein with lysoPLD activity was puriﬁed from plasma and
serum, and was found to be identical with a molecule
known as autotaxin [12,13]. Autotaxin [ENPP2 (ectonucleotide
pyrophosphatase/phosphodiesterase 2)] was originally cloned as
a tumour cell motility-stimulating factor and was recognized as a
nucleotide pyrophosphatase on the basis of its primary structure
and in vitro enzymatic characteristics [14]. LPC, which can bind
albumin and lipoproteins, is released into circulation from the
liverandmaybegeneratedbylecithin/cholesterolacyltransferase.
Autotaxin might hydrolyse these LPCs as substrates, and LPA
accumulated to levels greater than 50 μM in plasma, presumably
duetoverylowactivityofLPA-degradingenzymesinthatcontext
[7].
When cells are stimulated by hormones and proliferation
factors, equimolar amounts of free fatty acid and LPC are
produced from PC (phosphatidylcholine) by the activated PLA2
(phospholipase A2) [15]. The free fatty acids that are released,
including arachidonic acid, which is present at position sn−2o f
PC prior to cleavage, are converted into eicosanoids. Whereas
the metabolism of arachidonic acid has been well character-
ized, the metabolism of LPC is less well understood. Because the
accumulation of LPC in cells induces cell lysis [16], it has been
thought that LPC was easily hydrolysed by lysophospholipases
we cloned in a previous study [17], followed by conversion
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into a non-bioactive saturated free fatty acid and GPC (glycero-
phosphorylcholine).However,LPCitselfwasrecognizedrecently
as a bioactive phospholipid that can induce chemotaxis [18],
signal-responsive kinase activities [19] and atherosclerosis [20].
The ﬁrst enzyme with lysoPLD activity was isolated from
rat brain microsomes by Wykle and Schremmer [5]. The
characteristics of this intracellular enzyme, such as substrate
speciﬁcity, cation requirement and optimal pH, are different from
those of autotaxin. We puriﬁed a novel lysoPLD from the rat
brain that is a Mg
2+-dependent enzyme and utilizes lysoPAF (1-
O-hexadecyl-sn-glycero-3-phosphocholine) as a substrate [21],
similar to the enzyme reported by Wykle and Schremmer [5].
This enzyme might be involved in the production of LPA
from LPC, which is produced from PC hydrolysed by PLA2
in cells. Previously, it has been reported that LPA receptors are
expressed in perinuclear areas [22,23] and, furthermore, that the
transcription factor PPARγ (peroxisome proliferation-activator
receptor γ) is bound to LPA [24]. Based on these observations,
it seems reasonable to propose that intracellular lysoPLD is
important for cellular responses.
In the present study, we have identiﬁed a puriﬁed protein with
lysoPLDactivityfromtheratbrainastheheterotrimericGprotein
subunits Gαq and Gβ1. Mutations predicted to affect the binding
of nucleotide phosphates or Mg
2+ to the Gαq subunit resulted
in a dramatic reduction of lysoPLD activity. Moreover, several
types of Gα subunits, including Gαq and Gα11, exhibit lysoPLD
activity when expressed and puriﬁed as tagged proteins.
EXPERIMENTAL
Materials
LPC (1-palmitoyl, 16:0; stearoyl, 18:0; and oleoyl, 18:1)
was obtained from Sigma–Aldrich. LysoPAF was from Alexis
Biochemicals. 1-[
14C]Palmitoyl-2-lyso-phosphatidylcholine was
purchased from GE Healthcare. HPPA [3-(4-hydroxyphenyl)
propionic acid], peroxidase and choline oxidase were purchased
from Wako Chemicals. Silica Gel 60 plates and tag-puriﬁed
G(β1 and γ 2) complex overexpressed in Spodoptera frugiperda
insect cells were purchased from Merck, and CHAPS was
purchased from Dojindo. Antibodies against Gαq/11,G β1–4,a n d
Gγ 5 were obtained from Santa Cruz Biotechnology, and anti-
FLAG antibody, anti-FLAG afﬁnity gels, FLAG peptides, anti-
actin antibody and GTP were purchased from Sigma. The
monoclonalanti-autotaxinantibodywasobtainedfromDrJunken
Aoki (Graduate School of Pharmaceutical Sciences, Tohoku
University, Japan).
Identiﬁcation of puriﬁed lysoPLD
Puriﬁcation of lysoPLD from rat brain tissue was performed
exactly as described previously [21]. All steps in enzyme
puriﬁcation were carried out at 4◦C. Brieﬂy, rat brains were
minced and homogenized with a Teﬂon homogenizer in
9volumesofbufferA[0.3 Msucrosein50 mMTris/HCl(pH 7.4),
1 mM EDTA, 1 mM dithiothreitol and 0.1 mM PMSF). Nuclear
fractions were obtained by centrifugation at 600 g for 10 min and
resuspended in buffer A. To dissolve lysoPLD in the nuclear
pellets, 10 mM CHAPS was added and the suspension was
sonicated with a Microson Ultrasonic cell disruptor (Misonix).
The suspensions were then centrifuged at 10000 g for 10 min
and the supernatants were used as a source of enzyme. The
supernatants were applied to a DEAE Celluloﬁne A-500 column
equilibrated with buffer B [20 mM Tris/HCl (pH 7.5), 0.1 mM
PMSF and 5 mM CHAPS), and the enzyme was eluted with
a NaCl gradient. Active fractions were sequentially applied to
three different types of columns. The enzyme fractions were
concentratedusingMicroconcentrifugalﬁlterdevices(Millipore)
and then applied to a Superdex 200 10/300 GL column. As a
ﬁnal step, the eluted active fractions were applied to a HiTrap
DEAEFFcolumnusingaWaters650(Millipore).Theﬁnaleluted
fraction was then subjected to SDS/PAGE (10% gel) and the
gel was stained with EZ Stain Silver (Atto). The major protein
bands were excised for in-gel digestion with MS grade trypsin
(Wako Chemicals). The mass spectra of extracted peptides were
analysed by MALDI–TOF MS (matrix-assisted laser desorption
ionization–time-of-ﬂight MS) (Voyager Elite/STR Perspective,
Life Technologies), and the proteins were subsequently identiﬁed
using MS-Fit (http://prospector.ucsf.edu).
SDS/PAGE and immunoblotting
Proteins from rat brains and the FLAG tag afﬁnity gel-puriﬁed
fractions (10 μl) were separated on 10% acrylamide gels, and
stained with a silver staining kit (Wako Chemicals) or transferred
on to PVDF membranes using a semi-dry transfer apparatus
(Nippon Eido) and blocked with 5% skimmed milk in TBS-T
buffer [150 mM NaCl, 20 mM Tris/HCl (pH 8.0) and 0.05%
Tween 20]. The membranes were incubated overnight at 4◦C
with primary antibody diluted 1:1000 (anti-Gαq/11,- G β1–4,- G γ 5,
-actin or -autotaxin) or 1:5000 (anti-FLAG) in TBS-T and then
for 1 h at room temperature (20◦C) with a peroxide-conjugated
secondaryantibodydiluted1:5000inTBS-T.Reactivebandswere
detected by chemiluminescence using the Bio-Rad Laboratories
ChemiDoc XRS+ system.
Plasmid construction
N-terminally FLAG-tagged Gαq (GenBank® accession
number NM_031036.1), Gα11 (GenBank® accession number
NM_031033.1) or Gβ1 (GenBank® accession number NM_
030987.2) cDNAs were ampliﬁed from cDNAs from a rat
brain cDNA library using a forward primer containing the
FLAG tag sequence, then subcloned into the pcDNA3.1 V5/His
TOPO TA vector (Invitrogen). PCR was performed with the
following pairs of primers: Gαq,5
 -GGAAGAATGGACTACA-
AGGACGACGATGACAAGACTCTGGAGTCCATCATGG-3
 
and 5
 -TCACACCAGATTGTACTCCTTCAGG-3
 ;G α11,5
 -GC-
GACGATGGACTACAAGGACGACGATGACAAGACTCTG-
GAGTCCATGATG-3
  and 5
 -TCACACCAGATTGTACTCC-
TTCAGG-3
 ;a n dG β1,5
 -GTGAAGATGGACTACAAGGACG-
ACGATGACAAGAGTGAACTTGACCAGCTGC-3
  and 5
 -G-
TTCCAGATCTTGAGGAAG-3
 .T h eG αi (GenBank® accession
number NM_010305.1) and Gαs (GenBank® accession number
AK168996.1) cDNAs were ampliﬁed from a mouse brain
cDNA library with the primer pairs 5
 -AAAGAATTCGCCA-
CCATGGGCTGCAC-3
  and 5
 -AAACTCGAGTTCGAAGAG-
ACCACAGTCTTT-3
 ,a n d5
 -AAAGAATTCGCCGCCATGGG-
CTGCCTC-3
  and 5
 -AAACTCGAGTTAGAGCAGCTCGTAT-
TGGCG-3
  respectively. The amplicons were cloned into
pcDNA3.1 His/V5 after digestion with EcoRI and XhoI.
The FLAG tag was added via a site-directed mutagenesis ap-
proach using the following primers paired with their com-
plimentary sequences: Gαi,5
 -GAATTCGCCACCATGGA-
CTACAAGGACGACGATGACAAGGGCTGCACATTGAG-3
 ;
and Gαs,5
 -GAATTCGCCGCCATGGACTACAAGGACGA-
CGATGACAAGGGCTGCCTCGGC-3
 . Mutations were intro-
duced by site-directed mutagenesis using the following
primers paired with complimentary sequences: Gαq (G48V),
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5
 -CTGCTGCTGGGGACAGTCGAGAGTGGCAAG-3
 ;G αq
(G48A), 5
 -CTGCTGCTGGGGACAGCGGAGAGTGGCA-
AG-3
 ;G αq (K52A), 5
 -GACAGGGGAGAGTGGCGCGAGTA-
CCTTCATAAG-3
 ;Gαq (T186A),5
 -GTTCGAGTCCCCGCCA-
CAGGGATCATTG-3
 ;G αq (D205A), 5
 -TCTTCAGAATGGT-
CGCTGTAGGAGGCCAAAGG-3
 ;G αq (Q209L), 5
 -TGTAGG-
AGGCCTAAGGTCAGAGA-3
 ;a n dG β1 (H311A), 5
 -GTC-
CTAGCTGGAGCTGACAACCGAGTCAGC-3
 . The sequences
of the constructs were veriﬁed by direct DNA sequencing (ABI
PRISM 377-XL, Applied Biosystems).
LysoPLD assay
The isotopic lysoPLD activity assay was performed as described
previously [21]. Brieﬂy, 30 μl of the source of enzyme was
incubated at 37◦C for 6 h in a reaction mixture containing
0.15 mM 1-[
14C]palmitoyl-GPC (6000 d.p.m./nmol), 20 mM
Tris/HCl (pH 7.0), 1 mM Na3VO4, and 50 mM MgCl2 with or
without 1 mM GTP in a ﬁnal volume of 75 μl. The reactions
wereterminatedbytheadditionof15 μlof2 MHCland187.5 μl
of chloroform/methanol/HCl [100:200:1 (v/v)]. The lipids were
extracted by the addition of 93.75 μl each of chloroform and 2 M
KCl, followed by centrifugation at 500 g for 10 min at 20◦C.
The extracted lipids were subjected to two-dimensional TLC
[chloroform/methanol/28%ammoniaat65:35:5(v/v)fortheﬁrst
dimension and chloroform/acetone/methanol/acetic acid/water at
45:20:10:13:5 (v/v) for the second dimension]. The LPA spots
were visualized and quantiﬁed using the Fuji BAS2000 system
(Fujiﬁlm).
For the colorimetric assay to detect lysoPLD activity, the
amount of choline released from choline lysophospholipids was
used as a measure of enzyme activity. Puriﬁed proteins (40 μl)
were incubated at 37◦C with 0.15 mM (0.0375–0.6 mM) choline
lysophospholipids in the presence of 20 mM Tris/HCl (pH 7.0)
and1 mMNa3VO4 withorwithout50 mMMgCl2 and/or100 mM
EDTA in a total reaction volume of 200 μl. After incubation
for the given lengths of time, the reactions were terminated by
boiling. To determine the amount of choline released, a second
reaction was performed at 37◦C for 15 min in a 500 μl reaction
mixture containing the ﬁrst assay mixture plus 50 mM Tris/HCl
(pH 8.5), 0.5 mM HPPA, 0.033 unit/ml horseradish peroxidase
and 1 unit/ml choline oxidase. The ﬂuorescence intensity of each
mixture was determined by excitation at 320 nm and collection at
404 nm using an RF5300 instrument (Shimadzu).
Puriﬁcation of FLAG-tagged proteins
Mouse hepatocytoma cells (Hepa-1 cells), COS-7 cells or
Neuro2A cells were seeded into 100 mm dishes in DMEM
(Dulbecco’s modiﬁed Eagle’s medium; Wako Chemicals) with
10% fetal bovine serum (Gibco) 1 day prior to transfection. A
totalof24 μgofemptyvectororFLAG-taggedproteinexpression
vector were transfected into cells using Lipofectamine
TM 2000
(Invitrogen)accordingtothemanufacturer’sinstructions.At1 day
(24 h) post-transfection, the cells in one or ﬁve dishes were
collected in 800 μl/dish of buffer C [0.25 M sucrose in 50 mM
Tris/HCl (pH 7.4), 1 mM EDTA and 1 mM PMSF] and disrupted
by sonication (three to eight pulses of 10 s each) with a Microson
Ultrasonic cell disruptor. The homogenates were then centrifuged
at 105000 g for 1 h at 4◦C and the supernatants were removed or
usedforFLAG-taggedproteinpuriﬁcationasindicatedbelow.The
pellets were resuspended in 400 μl/dish of buffer C with 10 mM
CHAPS, and homogenized with an Ultrasonic cell disruptor.
The suspensions were diluted to 1600 μl/dish of buffer C, then
centrifuged at 21500 g for 10 min at 4◦C and the supernatants
were mixed with 250 μl of anti-FLAG M2 afﬁnity gel (Sigma–
Aldrich)suspendedin1.6 ml/dishofTBSbuffer[50 mMTris/HCl
(pH 7.4), 150 mM NaCl and 1mM PMSF]. After incubation with
gentle agitation at 4◦C for several hours, the gel was washed
with 5 ml of wash buffer (TBS with 0.1% CHAPS), and then
tagged proteins were eluted with 250 μl of 100 μg/ml FLAG
peptideinwashbufferfourtimes.Theviabilityofcellstransfected
with control or FLAG-tagged protein expression vectors did not
change over 24 h and nearly equal amounts of protein were
obtained in each sample.
Effect of mouse Gαq and Gα11 siRNAs (small interfering RNAs) on
lysoPLD activity in Hepa-1 cells
Stealth siRNA, a 25-base pair duplex oligoribonucleotide against
mouse Gαq or Gα11, was purchased from Invitrogen. The
target sense sequences were: Gαq,5
 -CCCUUUGACUUAC-
AAAGUGUCAUUU-3
 ;a n dG α11,5
 -CCAAGUUGGUGUA-
CCAGAACAUCUU-3
 . Hepa-1 cells (1×10
5) were cultured
in 60 mm dishes for 24 h, and then transfected with both
siRNAsbyusingLipofectamine
TM 2000(Invitrogen)accordingto
manufacturer’s instructions. After 48 h, the cells were collected
in 400 μl/dish of buffer C and disrupted by sonication (three
to eight pulses of 10 s each) with a Microson Ultrasonic cell
disruptor. The homogenates were then centrifuged at 105000 g
for 1 h at 4◦C and the supernatants were removed. The pellets
were resuspended in 300 μl/dish of buffer C with 10 mM
CHAPS, and homogenized with an Ultrasonic cell disruptor. The
suspensions were centrifuged at 21500 g for 10 min at 4◦C, and
the supernatants were used as microsomal fractions for lysoPLD
assay with 10 μg of the protein for a 30 min incubation.
Statistical analysis
All values are expressed as the means+ −S.D. (n3). Group
means were compared using the Student’s t test or ANOVA to
determinethesigniﬁcanceofthedifferencesamongtheindividual
means. Statistical signiﬁcance was assumed at P<0.05. Each
experiment was repeated at least twice with similar results.
RESULTS
A protein with lysoPLD activity is highly associated with
heterotrimeric G protein
In a previous study, we puriﬁed a novel protein with lysoPLD
activity from rat brain tissue and analysed its enzymatic
characteristics, which were different from those of the secreted
lysoPLD autotaxin. Initially, a 35 kDa protein was the main band
in puriﬁed lysoPLD from rat brain and did not react with an anti-
autotaxin antibody [21]. However, as shown in Figure 1(A), two
bands (faint 42 kDa and 35 kDa bands, indicated by arrows on the
right-hand side) were observed following repeated puriﬁcations
as reported previously [21], separation by SDS/PAGE and silver
staining. The 42 kDa protein was present at lower levels and was
not recognized as potentially important at ﬁrst. To identify their
molecularspecies,thebandswereanalysedbyPMF(peptidemass
ﬁngerprinting). The 42 kDa and 35 kDa proteins were identiﬁed
as Gαq (Figure 1D) and Gβ1 (Figure 1E) respectively.
To conﬁrm this result, the fractions obtained from the ﬁnal
step of enzyme puriﬁcation with HiTrap DEAE FF (Figure 1C)
were subjected to immunoblot analysis with antibodies speciﬁc
against Gαq/11 and Gβ1–4. As shown in Figure 1(B), both Gαq and
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Figure 1 Identiﬁcation of G protein subunits Gαq and Gβ1 in puriﬁed lysoPLD fractions from the rat brain
(A and B) Fractions eluted after HiTrap DEAE FF puriﬁcation, the ﬁnal step in a previously reported protocol for puriﬁcation of a lysoPLD activity from rat brain tissue, were subjected to SDS/PAGE
anddetectedbysilverstaining(A)andimmunoblotting(B).Theright-handsidearrowsin(A)indicateproteinbandsat42kDa(upper)and35 kDa(lower).(C)LysoPLDactivitiesofthesamepuriﬁed
samples obtained from rat brain tissue as determined using a colorimetric assay. (D and E) Identiﬁcation of the puriﬁed 42kDa and 35kDa proteins from rat brain tissues by PMF. The 42kDa (D)
and 35kDa (E) proteins were identiﬁed as Gαq and Gβ1 respectively. Amino acid sequences identiﬁed by PMF analysis are indicated with underlining. Fr., fraction.
Gβ1 proteins were detected in those fractions and the levels of
those proteins correlated well with lysoPLD activities in each
fraction. On the basis of these results, we speculated that the
heterotrimeric G protein complex is highly associated with
lysoPLD activity.
Tag-puriﬁed G protein exhibits lysoPLD activity
FLAG-tagged Gαq or Gβ1 proteins were overexpressed in the
mouse hepatocytoma cell line Hepa-1 and then puriﬁed via
immune-afﬁnity chromatography with an anti-FLAG antibody.
When overexpressed, FLAG–Gαq was puriﬁed with FLAG
peptides, endogenous Gβ co-puriﬁed and, similarly, endogenous
Gαq/11 co-puriﬁed with FLAG-tagged Gβ1 (Figure 2A). Gγ 5
also co-puriﬁed with FLAG–Gαq (Figure 2A). These results
suggest that heterotrimeric G protein complexes can form with
overexpressed FLAG–Gαq. The density of the immunoreactive
bands with anti-Gαq/11 or anti-Gβ1-4 antibody and lysoPLD
activities coincided well (Figures 2A and 2B); thus we used
fraction 4 for subsequent analyses. The signiﬁcant increase
in lysoPLD activity was not observed in fractions prepared
from cells transfected with empty vector. The lysoPLD
activity was conﬁrmed by choline production from lysoPAF
(Figure 2C) and LPA production from [
14C]palmitoyl-labelled
LPC, (Figures 2D and 2E). Signiﬁcant increases in both choline
and/or LPA production via lysoPLD activity were detected in the
eluatespreparedfromcellsoverexpressingFLAG–Gαq orFLAG–
Gβ1. Autotaxin was not detected in the tag-puriﬁed fraction
by immunoblot analysis (Figure 2A, indicated by the arrow),
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Figure 2 LysoPLD activity of tag-puriﬁed G protein subunits Gαq and Gβ1
Emptyvector(Cont)oravectorencodingFLAG-taggedGαq orGβ1 wastransfectedintoHepa-1
cellsandFLAG-taggedproteins(F-Gαq orF-Gβ1)werepuriﬁedfromonedish.(A)Immunoblot
analysisoftag-puriﬁedGproteinsubunitsGαq andGβ1.Atotalof10μlofeachsamplepriorto
puriﬁcation (lane 1), eluted with a wash buffer (lane 2) or eluted with elution buffers containing
FLAG-peptides(lanes3–6)wasseparatedbySDS/PAGE(10%gel)andtransferredontoPVDF
membranes. The immunoreacted Gαq,G β1,G γ 5, or autotoxin proteins (ATX) were detected
with anti-Gαq/11,- G β,- G γ 5 or -autotoxin antibodies. As expected, the molecular masses of
taggedproteinswereapproximately2kDalargerthanendogenousproteins.Theimmunoreacted
Gγ 5 in lane 1 and other lanes were determined in separated lanes, but on the same membrane.
The experiments were repeated several times and similar results were obtained each time. (B)A
total of 40μl of each fraction (lanes 2–6 in A) from Hepa-1 cells overexpressing empty vector
(open square) or FLAG-tagged Gαq (closed diamond) was incubated with 0.15mM lysoPAF
and then lysoPLD activities were calculated using a colorimetric assay. (C) A total of 40μl
of the second fractions eluted with FLAG peptides (lane 4 in A) obtained from Hepa-1 cells
overexpressing empty vector (white bar), F-Gαq (black bar) or F-Gβ1 (grey bar) was incubated
with 0.15mM lysoPAF for 6h and then lysoPLD activities were calculated using a colorimetric
assay. Results aremeans+ −S.D. (n=6).*P <0.001 comparedwith thevector control.(Dand
E)LPAproductionfrom[14C]-labelledLPCbyincubationwiththepuriﬁedenzymefromHepa-1
cells overexpressing empty vector (Cont) (white bar), FLAG-tagged Gαq (F-Gαq) (black bar)
or FLAG-tagged Gβ1 (F-Gβ1) (grey bar) for 6 h was visualized after lipids were extracted and
subjected to TLC analysis. Results are means+ −S.D (n=3). *P <0.012 compared with the
vector control. Arrows (E) indicate the positions of LPA. The experiments were repeated more
than three times with similar results.
and lower bands were non-speciﬁc bands. LysoPLD activity of
autotaxin is not dependent on Mg
2+ supplementation [25]. These
results suggest that the lysoPLD activities were attributable to
Gαq or Gβ1 themselves, or to a protein(s) in a complex with these
proteins.
Time course, substrate speciﬁcity and Mg2+ cation requirement of
lysoPLD activity of Gαq
To examine the time course of choline production from lysoPAF
hydrolysed by puriﬁed FLAG-tagged Gαq subunit, the enzyme
Figure 3 Time dependence, substrate speciﬁcity and requirement of Mg2+
cations of the lysoPLD activity of tag-puriﬁed Gαq
(A) A total of 40μl of the tag-puriﬁed fractions obtained from Hepa-1 cells overexpressing
empty vector (open squares, n=6) or FLAG-tagged Gαq (F-Gαq) (closed diamonds, n=6)
wasincubatedwith0.15mMlysoPAFfortheindicatedtimesandthensubjectedtoacolorimetric
lysoPLD assay. *P <0.01 compared with the vector control. (B) The puriﬁed F-Gαq (40μl)
wasincubatedwith0.15mMofvariouscholinelysophospholipids[16:0(blackbar,n=7),18:0
(grey bar, n=3), 18:1 (horizontally striped bar, n=6) or lysoPAF (white bar, n=5)] for 6h.
Relative choline production as compared with lysoPC (16:0) was analysed using a colorimetric
assay. *P <0.01 compared with 16:0; **P <0.001 compared with the other substrates. (C)
ThelysoPLDactivitiesofthefractions(40μl)obtainedfromHepa-1cellsoverexpressingempty
vector (white bar) or F-Gαq (black bar) were incubated with or without Mg2+ and/or EDTA
(n=3). Relative choline production as compared with F-Gαq and Mg2+ was analysed using
a colorimetric assay. *P  0.001 compared with F-Gαq and Mg2+
. (D) The supernatants of
homogenates from Hepa-1 cells overexpressing FLAG–Gαq after centrifugation at 105000g
were applied on to immune-afﬁnity chromatography with anti-FLAG antibody, and immunoblot
analysis of tag-puriﬁed Gαq (F-Gαq) was performed (top panel). The enzymatic activity in the
puriﬁed fraction was assayed (bottom panel). Results are means+ −S.D. The experiments were
repeated several times with similar results. Cont, control.
was incubated with 0.15 mM lysoPAF for 0–6 h and activities
were tested using a colorimetric assay. As shown in Figure 3(A),
the levels of the hydrolysed product, choline, signiﬁcantly
increased in the presence of puriﬁed FLAG-tagged Gαq for up
to 6 h of incubation.
To identify a preferred substrate, puriﬁed FLAG-tagged
Gαq was incubated for 6 h with several different choline
lysophospholipid substrates (Figure 3B). The preferred substrate
identiﬁed in this assay is lysoPAF (P<0.01). The enzyme was
more efﬁcient at hydrolysis of 1-palmitoyl-2-lyso-GPC (16:0)
than hydrolysis of 1-oleoyl-2-lyso-GPC (18:1) (P<0.01). The
substrate speciﬁcity of Gαq for lysophospholipids is very similar
to what was observed for the enzyme activity previously puriﬁed
from the rat brain [21]. Choline production from lysoPAF by the
puriﬁed FLAG–Gαq was dependent on incubation with Mg
2+
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(Figure 3C), similar to what was observed for the enzyme
puriﬁed from rat brain tissue [21]. Although after centrifugation
at 105000 g high levels of FLAG–Gαq could be puriﬁed from
the supernatants of homogenates from cells overexpressing the
protein, enzymatic activity was not detected (Figure 3D).
The lysoPLD activity of Gαq and Gβ1 mutant proteins
As FLAG–Gαq puriﬁed from Hepa-1 cells overexpressing the
protein co-puriﬁed with endogenous Gβ and puriﬁed FLAG-Gβ1
co-puriﬁed with endogenous Gαq/11 (Figure 2A), we next tried to
clarify which subunit is responsible for the lysoPLD activity we
observed. Autotaxin had been identiﬁed previously as a member
oftheecto-nucleotide PDE(pyrophosphatase/phosphodiesterase)
family due to similarity in its primary structure [14,26]. Later, it
became clear that the ester bond between phosphate and choline
in LPC was also hydrolysed by autotaxin [12,13]. Therefore
we speculated that Gαq subunit might exhibit lysoPLD activity
because it hydrolyses GTP to GDP via its intrinsic GTPase
activity. The Gβ1 subunit would be the candidate for the protein
with lysoPLD activity, as a histidine acid phosphatase consensus
motifispresentinitsC-terminus(V
305GILSGHDNAVSCLGV
320,
analysed by GENETYX). To test this, we introduced several
mutations at amino acid residues thought to be important
for Gαq or Gβ1 enzyme activities. The mutant proteins were
then puriﬁed and their lysoPLD activities were assayed. Tag-
puriﬁed Gβ1–Gγ 2 complex overexpressed in S. frugiperda
insect cells was also obtained, and its lysoPLD activity was
determined.
As shown in Figure 4(A), the K52A, T186A, D205A, G48A
and Q209L mutant forms of Gαq showed a signiﬁcant reduction
of lysoPLD activity, whereas G48V did not. The decrease in
lysoPLD activity of G48A and Q209L was low. Based on amino
acid sequence similarity to p21
ras, the amino acid sequence motif
G
46TGESGKS
53 is predicted to form a loop in which main-chain
amide hydrogens of several amino acids and the ε-amino group
of Lys
52 might form bonds with the β-a n dγ-phosphate of GTP
[27].ThissitealsocorrespondstotheGTP-bindingsite.Therefore
we speculated that the side chain of Lys
52 might be important
forthebindingofphosphateatthesn−3positionofLPC,whereas
thesidechainofGly
48 isnotlikelytobeimportantforthisbinding.
This suggests that the GTP- and LPC-binding sites or interacting
aminoacidsofGαq seemtobenotcompletelythesame.Moreover,
thesidechainofThr
186 maypointawayfromtheboundnucleotide
in the GDP-bound form, but ﬂip towards the nucleotide in the
GTP-boundform,whereitmightdirectlyinteractwithaMg
2+ ion
coordinated with oxygen molecules in the β-a n dγ-phosphates
of GTP. On the basis of crystal structure analysis, it has been
suggestedthatthesidechainofAsp
205 inGαq mightbindcatalytic
Mg
2+ via an intervening water molecule [27,28]. The well-
known dominant negative Gαq (Q209L) construct was prepared
and its activity was assayed. Only slight reduction of lysoPLD
activity of Q209L was detected. The Gβ1 mutant H311A, which
disrupts a conserved amino acid residue in the histidine acid
phosphatase consensus, did not show a signiﬁcant change in
lysoPLD activity as compared with the wild-type Gβ1 subunit
(Figure 4B). Tag-puriﬁed Gβ1–Gγ 2 complex overexpressed in
insectcellsdidnotexhibitlysoPLDactivity.Theseresultsstrongly
suggest that Gαq exhibits lysoPLD activity and, furthermore, that
the predicted nucleotide phosphate and Mg
2+-binding sites of the
protein are important for lysoPLD enzymatic activity. When we
puriﬁed lysoPLD from rat brain or culture cells, Gαq and Gβ
were always co-puriﬁed. It is possible that lysoPLD activity of
Gαq is dependent on the presence of Gβ protein.
Figure 4 LysoPLD activity of mutant forms of the G protein subunits Gαq
and Gβ1, and tag-puriﬁed Gβ1–Gγ 2 complex
Empty vector (Cont), FLAG-tagged wild-type Gαq (A,F - G αq)o rG β1 (B,F - G β1), or mutant
forms (A, T186A, K52A, D205A, G48V, G48A, Q209L mutations of Gαq,a n dB,F - G β1mf o r
Gβ1) were expressed in Hepa-1 cells and puriﬁed from one dish. Top panels: the levels of
unmodiﬁed or mutant FLAG-tagged Gαq and Gβ1 subunits in 10μl of the puriﬁed fractions,
and tag-puriﬁed Gβ1–Gγ 2 complex (3ng). The immunoreacted wild-type Gαq and mutant
forms in (A) were not determined in the same experiments, but all experiments were repeated
severaltimesandalmostequivalentlevelsofproteinscomparedwithF-Gαq wereobtainedeach
time. (A) Bottom panel: relative choline production by tag-puriﬁed enzymes (40μl) from cells
overexpressingemptyvector(Cont;whitebar,n=6),T186A(verticallystripedbar,n=5),K52A
(horizontallystripedbar,n=3),D205A(leftobliquestripedbar,n=3),G48V(greybar,n=4),
G48A (right oblique striped bar, n=3) or Q209L (crosswise striped bar, n=3) as compared
with unmodiﬁed FLAG-tagged Gαq (black bar, n=8) was analysed with a colorimetric assay
after incubation with 0.15mM lysoPAF for 6 h. *P <0.001 compared with FLAG-tagged Gαq.
(B)Bottompanel:relativecholineproductionbytag-puriﬁedenzymesfromcellsoverexpressing
empty vector (Cont; white bar, n=6), F-Gβ1m (horizontally striped bar; n=6) or tag-puriﬁed
Gβ1–Gγ 2 complex (12ng) [G(β1 and γ 2); black bar, n=3] as compared with F-Gβ1 (grey
bar;n=6).*P <0.001comparedwithF-Gβ1.Resultsaremeans+ −S.D.Theexperimentswere
repeated more than three times with similar results.
LysoPLD activity of Gαq protein and a mutant form, T186A, highly
puriﬁed from COS-7 cells
To eliminate the possibility that the detection of lysoPLD activity
from puriﬁed tagged Gαq protein is cell-line dependent, we
performed the same experiment with COS-7 cells, which do not
exhibit autotaxin activity and express relatively low endogenous
levels of G proteins. As shown in Figure 5(A), highly puriﬁed
wild-typeFLAG–Gαq proteinandamutantform,T186A,couldbe
detected following ectopic expression in COS-7 cells. The levels
of the hydrolysed product, choline, signiﬁcantly increased over
time in the presence of puriﬁed FLAG-tagged Gαq (Figure 5B).
The activity was dependent on incubation with Mg
2+ cations
(Figure 5C). The presence of lysoPLD activity was conﬁrmed by
the signiﬁcant production of choline from lysoPAF (Figures 5B–
5D) and LPA from LPC (Figures 5E and 5F). The T186A mutant
form of Gαq showed signiﬁcantly less lysoPLD activity than the
wild-typeFLAG–Gαq protein.TheseresultsclearlyshowthatGαq
has lysoPLD activity. As shown in Figure 5(A) (bottom panel),
a small amount of endogenous Gβ in COS-7 cells was also co-
puriﬁed with intact or mutated FLAG-tagged Gαq.
LysoPLD activity of Gβ1 protein highly puriﬁed from COS-7 cells
To examine the possibility that puriﬁed FLAG–Gβ1 obtained
from COS-7 cells also has lysoPLD activity, we repeated the
experiment described above with these cells. A small amount of
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Figure5 LysoPLDactivityofhighlypuriﬁedGαq proteinandamutantform,
T186A, from COS-7 cells
Empty vector (Cont), FLAG-tagged wild-type Gαq (F-Gαq) or a FLAG-tagged mutant form
(T186A) was expressed in COS-7 cells and puriﬁed from ﬁve dishes. (A) Silver staining (top
panel)orimmunoblotanalysis(bottompanel)withanti-Gαq/11 andGβ ofvectorcontrol(Cont),
tag-puriﬁed wild-type Gαq (F-Gαq) or T186A in the puriﬁed fractions. (B) A total of 40μlo f
the tag-puriﬁed fractions obtained from COS-7 cells overexpressing empty vector (Cont) (open
squares, n=3) or FLAG-tagged Gαq (F-Gαq) (closed diamonds, n=3) was incubated with
0.15mM lysoPAF for the indicated times and then subjected to a colorimetric lysoPLD assay.
*P <0.001comparedwiththevectorcontrol.(C)ThelysoPLDactivitiesofthepuriﬁedfractions
(40μl) obtained from COS-7 cells overexpressing empty vector (open bars) or F-Gαq (closed
bars)wereincubatedwithorwithoutMg2+ and/orEDTA(n=3).Relativecholineproductionas
comparedwiththevectorcontrolwasanalysedusingacolorimetricassay.*P <0.05compared
with the vector control and F-Gαq with or without Mg2+ and EDTA. (D) Choline production by
tag-puriﬁedenzymes(40μl)fromcellsoverexpressingunmodiﬁedFLAG-taggedGαq (F-Gαq)
(blackbar,n=3)orT186A(verticallystripedbar,n=3)wasanalysedwithacolorimetricassay
afterincubationwith0.15 mMlysoPAFfor6 h.**P <0.001comparedwithF-Gαq.(EandF)LPA
productionbytag-puriﬁedenzymes(30μl)fromcellsoverexpressingunmodiﬁedFLAG-tagged
Gαq (F-Gαq) (black bar, n=3) or T186A (vertically striped bar, n=3) was analysed with an
isotopic assay after incubation with 0.15mM [14C]-labelled LPC for 6 h. LPA production was
visualized after lipids were extracted and subjected to TLC analysis. (E)* P <0.03 compared
withF-Gαq.(F)ArrowsindicatethepositionsofLPA.Resultsaremeans+ −S.D.Theexperiments
were repeated at least twice with similar results.
endogenous Gαq/11 in COS-7 cells was co-puriﬁed with FLAG–
Gβ1 (Figure 6A). Almost the same lysoPLD activity as for
puriﬁed FLAG–Gαq protein was observed, in FLAG–Gβ1 with
the production of choline from lysoPAF (Figure 6B) and LPA
from LPC (Figure 6C). When puriﬁed FLAG–Gαq and FLAG–
Gβ1 proteinswereincubatedtogetherinvitro,anadditiveeffectof
lysoPLDactivitywasobserved,asspeciﬁcactivitydidnotchange
(Figure 6B).
Figure 6 LysoPLD activity of highly puriﬁed Gβ1 protein from COS-7 cells
FLAG-tagged wild-type Gαq (F-Gαq) or a FLAG-tagged wild-type Gβ1 (F-Gβ1) was expressed
in COS-7 cells and puriﬁed from ﬁve dishes. (A) Immunoblot analysis with anti-Gαq/11 (top
panel) and anti-Gβ (middle panel), or silver staining (bottom panel) of tag-puriﬁed wild-type
Gαq (F-Gαq)o rG β1 (F-Gβ1) in the puriﬁed fractions. (B) A total of 40 μl of the tag-puriﬁed
fractions obtained from COS-7 cells overexpressing FLAG-tagged Gαq (F-Gαq) (black bar,
n=3), FLAG-tagged Gβ1 (F-Gβ1) (grey bar, n=3) or equal amounts of both F-Gαq and
F-Gβ1 (white bar, n=3) was incubated with 0.15 mM lysoPAF for 6 h and then subjected to a
colorimetric lysoPLD assay. (C) The lysoPLD activity of the puriﬁed fraction (30μl) obtained
from COS-7 cells overexpressing F-Gαq (black bar, n=3) or F-Gβ1 (grey bar, n=3) was
analysed with an isotopic assay after incubation with 0.15mM [14C]-labelled LPC for 6h. LPA
production was visualized after lipids were extracted and subjected to TLC analysis. Results are
means+ −S.D. The experiments were repeated at least twice with similar results.
Effect of substrate concentration and GTP on the activity of
FLAG-puriﬁed lysoPLD from Neuro2A cells overexpressing
FLAG–Gαq
Because the lysoPLD enzyme that we have puriﬁed previously
was from the brain, we also tested overexpression and tag-
afﬁnity puriﬁcation of FLAG–Gαq using Neuro2A cells. As
shown in Figures 7(A) and 7(B), the level of lysoPLD activity of
puriﬁed FLAG-Gαq was dependent on cell type (COS-7<Hepa-1
<Neuro2A cells). Notably, the enzyme activity of puriﬁed
FLAG-tagged Gαq expressed in COS-7 cells was approximately
4 nmol/min per mg, whereas the activity from Neuro2A cells was
much higher, i.e. 137.4 nmol/min per mg. The calculated Km and
Vmax values for lysoPAF using Neuro2A cells were 21 μMa n d
0.16 μmol/min per mg respectively (Figures 7B and 7C). The Km
and Vmax values of lysoPLD obtained from rat brain for lysoPAF
were 26.7 μM and 0.29 μmol/min per mg respectively. These
results using Neuro2A cells and rat brain were almost equivalent
with each other. The slightly lower Vmax value in Neuro2A cells
is probably due to the purity of the enzyme or the disturbance of
enzyme activity by N-terminal FLAG peptides.
As shown in Figure 7(D), 1 mM GTP did not disturb the
lysoPLD activity (0.15 mM LPC) of FLAG–Gαq obtained from
Neuro2Acells.AsthemutationattheGTP-bindingregion(Gly
48)
did not decrease lysoPLD activity of Gαq much (Figure 4A), the
GTP- and LPC-binding sites seem to not be completely the same.
Moreover,theexchangeofGDPtoGTPandactivationofGTPase
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Figure 7 Effect of substrate concentration and GTP on the activity of FLAG-
puriﬁed lysoPLD obtained from Neuro2A cells overexpressing FLAG–Gαq
Empty vector (Cont) or FLAG-tagged wild-type Gαq (F-Gαq) was expressed in Hepa-1, COS-7
orNeuro2A(N2A)cellsandpuriﬁedfromﬁvedishes.(A)Immunoblotanalysiswithanti-Gαq/11
antibody (upper panel) of tag-puriﬁed Gαq (F-Gαq) obtained from Hepa-1, COS-7 or Neuro2A
cells overexpressing FLAG-Gαq. Choline production (lower panel) by tag-puriﬁed enzyme
(40μl)obtainedfromcellsoverexpressingunmodiﬁedFLAG-taggedGαq (F-Gαq)(n=3)was
analysed with a colorimetric assay after incubation with 0.15mM lysoPAF for 6 h. Results are
means+ −S.D.Theexperimentswererepeatedatleasttwotimeswithsimilarresults.Tag-puriﬁed
enzyme from Neuro2A cells overexpressing unmodiﬁed FLAG-tagged Gαq was incubated with
various concentrations from 0.0375 to 0.6mM of lysoPAF for 6 h, and choline production
was analysed with a colorimetric assay. An untransformed plot (B) and Lineweaver–Burk
(double-reciprocal) plot (C) are shown. (D) The lysoPLD activity of the puriﬁed fraction (30μl)
obtained from Neuro2A cells overexpressing empty vector or F-Gαq was analysed with an
isotopic assay after incubation with 0.15 mM [14C]-labelled LPC for 6h with (black bar, n=3)
or without (white bar, n=3) 1mM GTP. Relative LPA production was determined as compared
with FLAG-tagged Gαq without GTP. LPA production was visualized after lipids were extracted
andsubjectedtoTLCanalysis.Resultsaremeans+ −S.D.Theexperimentswererepeatedatleast
two times with similar results.
activity of Gαq possibly rarely occurred in this experiment.
As for most of the GTPases, the rate of exchange of GDP to
GTP and GTPase activity of Gαq are quite low without ligand-
stimulated receptor and GAPs (GTPase-activating proteins)
[29–31]. LysoPLD activity of autotaxin may be inhibited by
incubation with GTP because autotaxin catalyses the hydrolysis
o fG T Pa sw e l la sA T P .
LysoPLD activity of other Gα subfamily members and the effect of
Gαq and Gα11 siRNAs
In the human genome, 16 different Gα subunits have been
identiﬁed and these can be divided into four subfamilies based
on their amino acid similarities and the machinery for their signal
Figure 8 Testing LysoPLD activity of other Gα subfamily members and
effect of Gαq and Gα11 siRNAs
(A) FLAG-tagged Gα subtypes F-Gαq (black bar, n=18), F-Gα11 (grey bar, n=6), F-Gαi
(horizontally striped bar, n=6), F-Gαs (vertically striped bar, n=6) or empty vector (Cont;
white bar, n=12) were overexpressed in Hepa-1 cells and tagged proteins were puriﬁed from
one dish. Levels of tag-puriﬁed Gα subfamily proteins (top panel) and co-puriﬁed Gβ proteins
(middlepanel) detectedusinganti-FLAG andanti-Gβ1–4 antibodiesrespectively. NotethatGαs
migrates at a higher molecular mass than the others. The bands of the same size present in the
controlandexperimentalsamplesarenon-speciﬁc.Bottompanel:relativecholineproductionby
40μlofpuriﬁedenzymeincubatedwithlysoPAFascomparedwithFLAG-taggedGαq,detected
with a colorimetric assay. *P <0.001 compared with F-Gαq. Results are means+ −S.D. The
experiment was repeated several times with similar results. (B) Hepa-1 cells were pretreated
with control siRNA or mouse Gαq and Gα11 siRNAs for 48h. Levels of endogenous Gαq and
Gα11 (top panel) and actin (middle panel) detected using anti-Gαq/11 and anti-actin antibodies
respectively. Bottompanel:lysoPLDactivityinacrudemicrosomalfraction(10μg)fromHepa-1
cellspretreatedwithcontrolsiRNA(whitebar,n=3)orGαq andGα11 siRNAs(blackbar,n=3)
was analysed with a colorimetric assay after incubation with 0.15mM lysoPAF for 30min.
transduction. Thus we were interested in the possibility that other
Gα protein family members might also exhibit lysoPLD activity.
To test this, we ﬁrst constructed plasmids encoding FLAG-tagged
Gα11,G αi and Gαs. The plasmids were introduced into Hepa-1
cells and the activities of the puriﬁedoverexpressed proteins were
analysed. As shown in Figure 8(A), puriﬁed FLAG–Gα11, which
has 89% sequence similarity with Gαq and belongs to the same
subfamily, exhibited a high lysoPLD activity (P<0.01), whereas
FLAG–Gαi and FLAG–Gαs did not. However, a slight increase
in lysoPLD activity of FLAG–Gαs was observed.
AsshowninFigure8(B),pretreatmentofGαq andGα11 siRNAs
clearly decreased the endogenous Gαq and Gα11 in Hepa-1 cells.
However, lysoPLD activity in the crude microsomal fraction did
not changed compared with the control. In the crude microsome,
wespeculatedthatotherundeterminedGproteinsorcontaminated
autotaxin may be responsible for the high endogenous lysoPLD
activity and that the lysoPLD activity of the interested protein
may be masked.
DISCUSSION
We were interested to molecularly identify a lysoPLD activity
that had been reported previously. Two proteins from the rat brain
exhibiting lysoPLD activity (faint 42 kDa and 35 kDa bands by
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gel electrophoresis) can be observed following a method reported
previously for puriﬁcation [21]. As shown in Figure 1(A), the
42 kDa protein was present at lower levels and, at ﬁrst, was not
recognized as potentially important. The enzymatic properties of
the fractions containing both proteins, including optimum pH,
substrate speciﬁcity and cation requirement, were different from
those of a secreted protein with lysoPLD activity, autotaxin. In
the present study, we analysed the 42 kDa and 35 kDa proteins by
MS and identiﬁed them as the heterotrimeric G protein subunits
Gαq and Gβ1 respectively. When FLAG-tagged Gαq or Gβ1 was
overexpressed in Hepa-1 cells and puriﬁed, both puriﬁed subunits
exhibited lysoPLD activity (Figure 2). Mutations in conserved
amino acid residues of Gαq known to be important for GTPase
activity and interaction with nucleotide phosphates or Mg
2+
signiﬁcantly reduced lysoPLD activity (Figure 4). Furthermore,
highly puriﬁed FLAG–Gαq protein ectopically expressed in
COS-7 cells clearly hydrolysed LPC to LPA, whereas a
mutant form, T186A, showed signiﬁcantly less lysoPLD activity
(Figure 5). The calculated Km and Vmax values for lysoPAF of
the FLAG-puriﬁed enzyme obtained from Neuro2A cells were
21 μM and 0.16 μmol/min per mg respectively (Figures 7B and
7C). These values were similar to the enzyme puriﬁed from the
rat brain (Km =26.7 μMa n dVmax =0.29 μmol/min per mg) (21).
Although Gβ1 detected by silver staining was the main protein
of puriﬁed lysoPLD from rat brain, Gβ1 is not likely to be the
main component for lysoPLD activity because of following four
reasons: (i) FLAG–Gβ1 mutant (H311A) exhibited signiﬁcant
lysoPLD activity (Figure 4B); (ii) FLAG–Gα11 co-puriﬁed with
lower amounts of Gβ1 exhibited lysoPLD activity comparable
with Gαq (Figure 8A); (iii) FLAG–Gαi and FLAG–Gαs did not
exhibit as high a lysoPLD activity as FLAG–Gαq when they
were co-puriﬁed with Gβ (Figure 8A); and (iv) tag-puriﬁed Gβ1
and Gγ 2 overexpressed in insect cells did not exhibit lysoPLD
activity (Figure 4A). However, the potential importance of Gβ1
for lysoPLD activity of Gαq may be possible because they were
always co-puriﬁed with respect to lysoPLD activity. These results
reveal a new function for Gαq and Gβ1, which are well known as
multifunctional signal transduction proteins, as an enzyme with
lysoPLD activity.
Although FLAG-puriﬁed Gαq obtained from the microsomal
fraction exhibited signiﬁcant lysoPLD activity, the puriﬁed
enzyme from supernatants after 105000 g centrifugation did
not have lysoPLD activity (Figure 3D). The level of lysoPLD
activity of puriﬁed FLAG–Gαq from the microsomal fraction
was dependent on cell type (COS-7<Hepa-1<Neuro2A cells)
(Figure 7A). These results suggest that post-translational
modiﬁcation(s), or some kind of activator(s) present in the
microsome, is important for lysoPLD activity of Gαq.H o w e v e r ,i t
is also possible that Gαq proteins in supernatants were misfolded
after translation.
Agonist-activated GPCRs enhance GDP/GTP exchange on
the G protein α subunit, thereby generating an active GTP-
boundGα subunit,followedbydissociationfromthereceptorand
Gβγ subunit. The onset and termination of G protein signalling
is determined by the length of time spent in the active GTP-
bound state. GTP is hydrolysed to GDP by the intrinsic GTPase
activity of the Gα subunit, resulting in re-association of the
Gα subunit with the Gβγ subunit and termination of signalling
[29]. As for most of GTPases, the rates of exchange of GDP to
GTP and GTPase activity of Gαq are quite low. However, the
GTPase activity of Gαq can be dramatically increased by in vitro
incubationwithligand-stimulatedcholinergicreceptorandGAPs,
such as the RGS (regulator of G protein signalling) proteins [30]
or phospholipase C [31]. In the present study, we found evidence
that the lysoPLD activity of FLAG-tagged Gαq is exhibited in the
presence of Gβ and Gγ 5, as endogenous Gβ and Gγ 5 co-puriﬁed
with FLAG–Gαq (Figure 2). We speculate that the heterotrimeric
form of G protein subunits may exhibit lysoPLD activity.
Previously, GTPγS was found to be bound to the
puriﬁed activators [32] and, additionally, that puriﬁed PI-PLC
(phosphoinositide phospholipase C) from the bovine brain could
be activated by puriﬁed Gαq in the presence of GTPγS (0.1–
1 mM)[33].Onthebasisofourresults,weproposethatapossible
role of the novel lysoPLD identiﬁed in the present study for Gαq
andGβ1 istheproductionofLPAinsidecellsinresponsetoligand
stimulation, which is then followed by sequential activation of
PI-PLC (Ca
2+ inﬂux) and PLA2s that hydrolyse PC to free fatty
acid and LPC [15]. It was reported previously that LPA receptors
can be detected on the nuclear membrane [22,23] and that the
transcription factor PPARγ acts as a LPA receptor [24]. It seems
reasonable to speculate that the Gαq and Gβ1 subunits mediate
the signal to these intracellular receptors via lysoPLD activity.
After testing several family members as shown in Figure 8(A),
Gαq and Gα11 exhibit a high lysoPLD activity, but Gαi and
Gαs do not. Therefore we conclude that the lysoPLD activity
of the Gα subunit is strictly dependent on its subfamily. However,
treatment of Hepa-1 cells with Gαq and Gα11 siRNAs did not
affect lysoPLD activity in the microsomal fraction (Figure 8B).
It may be possible that other undetermined G proteins and/or
different kinds of lysoPLD, such as autotaxin, are responsible
for the high endogenous lysoPLD activity and that they masked
the reduced activity. Furthermore, our preliminary experiments
showed that the stimulation of radio-labelled cells by carbachol
thatactivatesGαq/11 throughthemuscarinicreceptordidnotaffect
the basal amount of LPA (results not shown). We speculate that
the degradation of LPA in cells was rapid or that the stimulation
system was inadequate. Further investigation is required to help
elucidate the importance of LPA production by Gαq in signal
transduction.
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